Kitch Wilson
Inversor de Capital Privado en Pioneer Fund/NY/ .
Cargos activos de Kitch Wilson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Pioneer Fund/NY/
 Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Inversor de Capital Privado | 01/10/2023 | - |
Historial de carrera de Kitch Wilson
Antiguos cargos conocidos de Kitch Wilson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Bell Biosystems, Inc.
 Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Consultor / Asesor | 01/01/2011 | 01/04/2014 |
Formación de Kitch Wilson.
| Stanford University | Graduate Degree |
| Duke University School of Medicine | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Graduate Degree | 2 |
| Private Equity Investor | 1 |
| Consultant / Advisor | 1 |
Sectorial
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Finance |
Bell Biosystems, Inc.
Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Kitch Wilson
- Experiencia
